PRINCIPAL INVESTIGATOR

Paola Alberti

paola alberti

Dr. Paola Alberti, MD, PhD, is a postdoctoral research fellow at University of Milano-Bicocca (UNIMIB).
Her main field of interest is Chemotherapy Induced Peripheral Neurotoxicity (CIPN) at clinical and preclinical level. She is an active member of the Toxic Neuropathy Consortium (TNC), part of the Peripheral Nerve Society (PNS).
Since August 2016 she is consultant Neurologist at San Gerardo Hospital (ASST Monza, Italy).

Curriculum vitae

Paola Alberti, MD, PhD

Dr. Paola Alberti, MD, PhD, is a postdoctoral research fellow at University of Milano-Bicocca (UNIMIB).

  • Degrees:

    • 2010: MD (110/100L, Università degli studi di Milano-Bicocca)
    • 2011: medical state examination (esame di stato per medico-chirurgo, Università degli studi di Milano-Bicocca)
    • 2016: Board in Neurology (70/70L, Università degli studi di Milano-Bicocca)
    • 2019: PhD in neuroscience (Università degli studi di Milano-Bicocca)

Research and professional experience: her main field of interest is Chemotherapy Induced Peripheral Neurotoxicity (CIPN) at clinical and preclinical level. She is an active member of the Toxic Neuropathy Consortium (TNC), part of the Peripheral Nerve Society (PNS). Since August 2016 she is consultant Neurologist at San Gerardo Hospital (ASST Monza, Italy): she is the treating physician for outpatients affected by CIPN (“Ambulatorio di Fragilità Neurologica”).

Publications: she authored di 65 publications on peer-review international journal; ID scopus: 7103068082, H-index 25, 2000 citations since 2010.

Positions and honors: co-chair of the CIPN working group of the “Multinational Association of Supportive Care in Cancer” (since 2020); member of the web committee (since 2020) and of the Junior committee (since 2021) of the PNS, and ex-officio (non-voting) member of the board of the TNC (since 2021); member of the editorial board of the International Journal of Molecular Science (since 2020); responsible of human anatomy teaching courses at UNIMIB since 2016 and at Lunex University (Luxembourg) since 2020.

Awards: recipient as Principal Investigator of Bicocca Starting grant (personal grant: 55,000 euros) for a research project aiming at assessing socio-economic burden related to CIPN; AIPN 2018 prize for the best oral communication at ASNP meeting 2018 (Roma) for the contribution: “Oxaliplatin Induced Peripheral Neurotoxicity: a rat model that reproduces acute and chronic phenomena” (http://www.neuropatia.it/?p=310); Second place at the Italian Falling Wall Labs 2017 selection (Casale di Monferrato) with the presentation “Breaking the wall of Chemotherapy Induced Peripheral Neurotox” (https://www.ilmonferrato.it/articolo/Jcn_67YIVUeaUmNfCALLLw/e-di-chiara-l-idea-migliore-dei-falling-walls-del-sobrero); Travel grants as presenting author (oral communication): ASNP meeting 2013 (Verona), PNS meeting 2013 (Saint Malò, Francia), ASNP meeting 2014 (Sorrento), EFNS 2014 (Istanbul, Turchia), PNS meeting 2015 (Quebec City, Canada), SIN 2016 (Venezia), SIN 2017 (Napoli), ASNP 2018 (Roma), ASNP 2019 (Padova).